Bristol-Myers Squibb Company

BMY

Healthcare

$56.50

4.42%Fair Value

Bristol-Myers Squibb Company (BMY) is a Healthcare company that currently yields 4.42% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $48.04 and the overvaluation threshold at $78.55. Bristol-Myers Squibb Company holds a quality score of 38/100 (Risky), reflecting 4 consecutive years of dividend growth with a 70% payout ratio. The 5-year dividend CAGR stands at 1.6%.

BMY Dividend Yield History — Weiss Valuation

Underval. $48.04Overval. $78.55

Price

Undervalued band

Overvalued band

Why Now?

Bristol-Myers Squibb Company is trading at a fair valuation relative to its dividend history.

Current yield 4.4% vs historical max 5.2% (85% of maximum).

4 years of uninterrupted dividends.

Reasonable payout ratio of 70%.

Dividend Compounder (DRIP)

Initial Investment

Horizon (years)

Div. CAGR (%)

Year 1 Income

$450

Year 10 Income

$790

Yield on Cost

8.31%

Total Income

$6,032

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Quality Score

Risky

Payout Ratio5/25

Dividend Streak5/25

Growth (CAGR 5Y)3/20

Yield vs History15/15

FCF Coverage10/15

Key Metrics

Current Price$56.50

Annual Dividend$2.50

Current Yield4.42%

Yield — Max (10Y)5.20%

Yield — Min (10Y)3.18%

Undervalued Below$48.04

Overvalued Above$78.55

Payout Ratio70.03%

CAGR Dividend 5Y1.6%

CAGR Dividend 10Y—

Years No Cut4y

consecutive years of dividend growth

In-depth analysis

→ BMY Dividend Analysis Article